References
- Koch-Weser J. Serum drug concentrations as therapeutic guides. N Engl J Med 1972:287:227–31
- Werner M, Sutherland EW 3d, Abramson FP. Concepts for the rational selection of assays to be used in monitoring therapeutic drugs. Clin Chem 1975:21:1368–71
- Greenblatt DJ, Koch-Weser J. Clinical pharmacokinetics I. N Engl J Med 1975:293:702–5
- Greenblatt DJ, Koch-Weser J. Clinical pharmacokinetics II. N Engl J Med 1975;293:964–70
- Gibaldi M, Levy G. Pharmacokinetics in clinical practice. 1. Concepts. JAMA 1976:235:1864–7
- Gibaldi M, Levy G. Pharmacokinetics in clinical practice. 2. Applications. JAMA 1976;235:1987–92
- Werner M. Management of apparently inappropriate therapeutic drug monitoring data. Lab Med 1980:11:818–20
- Jatlow P. Therapeutic monitoring of plasma concentrations of tricyclic antidepressants: perspective of the clinical laboratory. Arch Pathol Lab Med 1980; 104:341–4
- Greenblatt DJ, Duhme DW, KochWeser J, et al. Evaluation of digoxin bioavailability in single-dose studies. N Engl J Med 1973:289:651–4
- Bigger JT Jr. The quinidine-digoxin interaction: what do we know about it? (Editorial) N Engl J Med 1979:301:779–81